This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Accelrys Announces Chr. Hansen Deployment Of ILabber ELN To 300 Users

Stocks in this article: ACCL

Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, is pleased to announce that Chr. Hansen has selected the on-premise iLabber electronic lab notebook (ELN) from Accelrys’ wholly-owned subsidiary Contur for global knowledge management across the enterprise. The iLabber notebook (previously the ConturELN) is a proven, cost-effective, server-based system that improves process documentation, information sharing and reuse, IP protection and overall productivity for leading biotechnology, chemical and food and beverage companies, as well as universities.

“We chose the iLabber system because it met our high quality requirements for a global deployment,” said Dr. Morten Meldgaard, project director of Chr. Hansen’s ELN project. “Of all the products we assessed, iLabber scored highest overall in simplicity and ease-of-use; out-of-the-box fit with current IT platforms; and low total cost-of-ownership with minimal training required.”

“Chr. Hansen’s selection of iLabber confirms the benefits of the notebook’s flexible, out-of-the-box capabilities and turnkey ease-of-deployment,” said Thomas Rozlucki, managing director of Contur, a wholly-owned subsidiary of Accelrys. “The global ELN roll-out at Chr. Hansen is a reflection of iLabber’s continuing rapid adoption and deployment in the food and beverage industry.”

Chr. Hansen is a leading supplier of natural colors and bacterial cultures for the food industry. With 2,300 employees and application centers in more than 20 countries, the company initiated an aggressive ELN rollout requiring full deployment within two years. A pilot study with 60 Chr. Hansen employees running iLabber began in March 2011 and the final decision for global deployment was made in August. The system is currently deployed to 300 users.

As part of the pilot study, Chr. Hansen has successfully integrated iLabber with several critical internal systems, including project portfolio and SAP systems, improving quality, consistency and transparency of documentation enterprise-wide.

iLabber is available as both an on-premise, server-based installation and a cloud-based Software-as-a-Service offering. Both systems are well-suited for R&D organizations requiring high-quality documentation and efficient sharing of experimental work along with rapid deployment and cost-effective operation. For more information on iLabber and other organizations using iLabber solutions, visit www.ilabber.com.

About Accelrys, Inc.

Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on science as a differentiator. Accelrys’ Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. Through its Enterprise R&D Architecture and market-leading electronic laboratory notebooks (ELNs), Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs